prof. Guy Laureys

Phenotyping vestibulocochlear manifestations in Susac syndrome : a cohort study

Astrid Roelens (UGent) , Maria Vandekerckhove, Leen Maes (UGent) , Cathérine Dekeyser (UGent) , Dimitri Hemelsoet (UGent) , Veroniek Van Driessche (UGent) , Marijke Miatton (UGent) , Liesbeth Van Hijfte (UGent) , Julie De Zaeytijd (UGent) , Tineke Van Vrekhem (UGent) , et al.

(2025) EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 282(3). p.1189-1200

Add to list

Journal Article
A1
open access

Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD : a multicentre study

Pakeeran Siriratnam, Paul Sanfilippo, Anneke van der Walt, Sifat Sharmin, Yi Chao Foong, Wei Zhen Yeh, Chao Zhu, Samia Joseph Khoury, Tunde Csepany, Barbara Willekens, et al.

(2025) JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 96(4). p.361-369

Add to list

Journal Article
A2
open access

Proteomics dataset of lysolecithin-induced demyelinated lesions in corpus callosum of Lewis rats, treated with Vagus nerve stimulation or sham treatment

Helen Bachmann (UGent) , Boris Vandemoortele (UGent) , Vanessa Vermeirssen (UGent) , Evelien Carrette (UGent) , Kristl Vonck (UGent) , Paul Boon (UGent) , Robrecht Raedt (UGent) and Guy Laureys (UGent)

(2024) DATA IN BRIEF. 57.

Add to list

Journal Article
A1
open access

Disease activity in pregnant and postpartum women with multiple sclerosis receiving ocrelizumab or other disease-modifying therapies

Wei Z. Yeh, Anneke Van Der Walt, Olga G. Skibina, Tomas Kalincik, Raed Alroughani, Allan G. Kermode, Marzena J. Fabis-Pedrini, William M. Carroll, Jeannette Lechner-Scott, Cavit Boz, et al.

(2024) NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 11(6).

Add to list

Journal Article
A1
open access

The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries : a propensity-score-matched cohort study

David Levitz, Yi Chao Foong, Paul Sanfilippo, Tim Spelman, Louise Rath, Angie Roldan, Anoushka Lal, Mastura Monif, Vilija Jokubaitis, Serkan Ozakbas, et al.

(2024) THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 17.

Add to list

Journal Article
A1
open access

Utility of icobrain for brain volumetry in multiple sclerosis clinical practice

Ai-Lan Nguyen, Maria Pia Sormani, Dana Horakova, Eva H Havrdova, Michael H Barnett, Nicola De Stefano, Marco Battaglini, Manuela Vaneckova, Elaine Lui, Frank Gaillard, et al.

(2024) MULTIPLE SCLEROSIS AND RELATED DISORDERS. 92.

Add to list

Optimization of focal experimental autoimmune encephalomyelitis induced in the rat corpus callosum

Helen Bachmann (UGent) , Robrecht Raedt (UGent) and Guy Laureys (UGent)

(2024) 18th European School Neuroimmunology Course (ESNI2024), Abstracts.

Add to list

Journal Article
A1
open access

Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis : a longitudinal analysis of global and national registries

Sifat Sharmin, Izanne Roos, Charles B Malpas, Pietro Iaffaldano, Marta Simone, Massimo Filippi, Eva Kubala Havrdova, Serkan Ozakbas, Vincenzo Brescia Morra, Raed Alroughani, et al.

(2024) LANCET CHILD & ADOLESCENT HEALTH. 8(5). p.348-357

Add to list

Journal Article
A1
open access

A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic

Anoushka P. Lal, Yi Chao Foong, Paul G. Sanfilippo, Tim Spelman, Louise Rath, David Levitz, Marzena Fabis-Pedrini, Matteo Foschi, Mario Habek, Tomas Kalincik, et al.

(2024) JOURNAL OF NEUROLOGY. 271. p.5813-5824

Add to list

Journal Article
A1
open access

Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis

Izanne Roos, Sifat Sharmin, Charles Malpas, Serkan Ozakbas, Jeannette Lechner-Scott, Suzanne Hodgkinson, Raed Alroughani, Sara Eichau Madueño, Cavit Boz, Anneke van der Walt, et al.

(2024) MULTIPLE SCLEROSIS JOURNAL. 30(9). p.1163-1175

Academic Bibliography

prof. Guy Laureys

Phenotyping vestibulocochlear manifestations in Susac syndrome : a cohort study

Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD : a multicentre study

Proteomics dataset of lysolecithin-induced demyelinated lesions in corpus callosum of Lewis rats, treated with Vagus nerve stimulation or sham treatment

Disease activity in pregnant and postpartum women with multiple sclerosis receiving ocrelizumab or other disease-modifying therapies

The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries : a propensity-score-matched cohort study

Utility of icobrain for brain volumetry in multiple sclerosis clinical practice

Optimization of focal experimental autoimmune encephalomyelitis induced in the rat corpus callosum

Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis : a longitudinal analysis of global and national registries

A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic

Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis

Contents

Support

Contact